With 1.81 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.79 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $15.38 whereas the lowest price it dropped to was $10.57. The 52-week range on STSS shows that it touched its highest point at $2145.00 and its lowest point at $3.36 during that stretch. It currently has a 1-year price target of $22.00. Beta for the stock currently stands at 2.53.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of STSS was up-trending over the past week, with a rise of 84.23%, but this was up by 183.47% over a month. Three-month performance surged to 261.33% while six-month performance fell -84.14%. The stock lost -97.81% in the past year, while it has lost -99.21% so far this year.
Float and Shares Shorts:
At present, 1.02 million STSS shares are outstanding with a float of 1.00 million shares on hand for trading. On 2025-08-15, short shares totaled 61431.0, which was 600.0 higher than short shares on 1752537600. In addition to Mr. Paul Kruger Danner III as the firm’s Executive Chairman & Principal Executive Officer, Mr. Andrew R. Crescenzo CPA serves as its Chief Financial Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, STSS reported revenue of $222722.0 and operating income of -$3006382.0. The EBITDA in the recently reported quarter was -$9334711.0 and diluted EPS was $3.58.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With STSS analysts setting a high price target of 22.0 and a low target of 22.0, the average target price over the next 12 months is 22.0. Based on these targets, STSS could surge 62.36% to reach the target high and rise by 62.36% to reach the target low. Reaching the average price target will result in a growth of 62.36% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$990 being high and -$990 being low. For STSS, this leads to a yearly average estimate of -$990. Based on analyst estimates, the high estimate for the next quarter is -$0.65 and the low estimate is -$0.65. The average estimate for the next quarter is thus -$0.65.
